COMBINATION CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY FOR REFRACTORY OVARIAN-CARCINOMA - IMPACT ON SURVIVAL

被引：0
|
作者：
MARKMAN, M
HOWELL, SB
机构：
[1] MEM SLOAN KETTERING CANC CTR, NEW YORK, NY 10021 USA
[2] UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA
来源：
CLINICAL RESEARCH | 1986年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A882 / A882
页数：1
相关论文
共 50 条
  • [41] HIGH-DOSE CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CARCINOMA
    HAINSWORTH, JD
    BURNETT, LS
    JONES, HW
    GROSH, WW
    JOHNSON, DH
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 502 - 508
  • [42] PREDICTION OF EFFECTIVENESS OF INTRAPERITONEAL CHEMOTHERAPY BY INTRAPERITONEAL SCINTIGRAPHY IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA
    SUGIMURA, K
    OKIZUKA, H
    KAJI, Y
    ISHIDA, T
    IWANARI, O
    KITAO, M
    CLINICAL NUCLEAR MEDICINE, 1994, 19 (07) : 600 - 603
  • [43] IMPLANTATION METASTASIS ALONGSIDE AN INTRAPERITONEAL CHEMOTHERAPY CATHETER IN OVARIAN-CARCINOMA
    WARNOCK, NG
    RILEY, M
    ABDOMINAL IMAGING, 1995, 20 (03): : 262 - 263
  • [44] Two patients with ovarian cancer refractory to cisplatin-based chemotherapy managed by a new combination chemotherapy with irinotecan hydrochloride and mitomycin-C
    Ken Takizawa
    Yoh-ichi Satow
    Yoshio Kato
    Takashi Kawana
    International Journal of Clinical Oncology, 1997, 2 (4) : 238 - 242
  • [45] 2ND-LOOK LAPAROTOMY IN OVARIAN-CARCINOMA PATIENTS AFTER 8 AND AFTER 12 COURSES OF CISPLATIN-BASED CHEMOTHERAPY
    MENCZER, J
    BENBARUCH, G
    MODAN, M
    BRENNER, H
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1989, 27 (02) : 102 - 104
  • [46] Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy
    Nakayama, S
    Nakayama, K
    Takebayashi, Y
    Hata, K
    Fujiwaki, R
    Fukumoto, M
    Miyazaki, K
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 11 (05) : 621 - 625
  • [47] Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
    Pande, Shripad B.
    Doval, D. C.
    Pavithran, K.
    Sharma, J. B.
    Shirali, Rashmi
    Jena, A.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (01) : 42 - 47
  • [48] EFFECTIVENESS OF COMBINATION CISPLATIN-BASED INTRAVESICAL CHEMOTHERAPY FOR BCG-REFRACTORY BLADDER CANCER
    Vila-Reyes, Helena
    Decastro, G. Joel
    Faiena, Izak
    Pak, Jamie S.
    Lee, Kevin
    Li, Gen
    Anderson, Christopher B.
    Abate-Shen, Cory T.
    McKiernan, James M.
    JOURNAL OF UROLOGY, 2020, 203 : E1124 - E1124
  • [49] CISPLATIN COMBINATION CHEMOTHERAPY VERSUS CHLORAMBUCIL IN ADVANCED OVARIAN-CARCINOMA - MATURE RESULTS OF A RANDOMIZED TRIAL
    WILLIAMS, CJ
    MEAD, GM
    MACBETH, FR
    THOMPSON, J
    WHITEHOUSE, JMA
    MACDONALD, H
    HARVEY, VJ
    SLEVIN, ML
    LISTER, TA
    SHEPHERD, JH
    GOLDING, P
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) : 1455 - 1462
  • [50] CHEMOTHERAPY CONSISTING OF CISPLATIN, EPIRUBICIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CARCINOMA
    STOOT, J
    WILS, J
    VONGEUNS, H
    SMEETS, J
    SCHOUTEN, L
    CANCER INVESTIGATION, 1993, 11 (01) : 1 - 5
12345